• 一项开放标签，单剂量研究，用于评估西那卡塞在接受透析的 28 天至<6 岁儿童慢性肾病患者中的安全性，耐受性，药代动力学和药效学 An open-label, single-dose study to evaluate the safety, tolerability,pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis
• 维生素 D 和西那卡塞与腹膜透析的存活率增加相关，但与残肾功能丧失无关 Vitamin D and cinacalcet are associated with increased survival in peritoneal dialysis but not with residual renal function preservation
• 拟钙剂对透析患者长期预后的影响：文献综述和贝叶斯荟萃分析 Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis
• 在非透析慢性肾脏病和继发性甲状旁腺功能亢进症患者中西那卡塞的长期有效性 Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
• 钙敏感受体的活化减弱了 TRPV6 依赖性肠钙吸收 Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption

页面